日本參天制藥Santen Pharmaceutical
參天制藥從1890年創業開始,作為一個從事處方藥品以及非處方藥品的研究、開發、生產、銷售的企業,一直為人們的眼睛和身體的健康保持和提高作出著不斷的貢獻。
現在,作為一個集中致力于眼科和風濕病的專業性企業,在占本公司銷售額80%的眼科處方藥領域,我們針對所有的眼科疾病開發生產優質的醫藥品,并根據醫療現場的需求積極提供信息,在日本國內取得了No.1的地位。
此外,以眼科處方藥事業為中心,已在日本美國歐洲三方面構筑了臨床開發·銷售體制,提供給世界以卓越的研究開發能力為根本的有獨特性的產品,成為在世界上有存在意義的企業是我們的目標。
■處方藥
[眼科處方藥]
在日本國內的市場占有率約為4成,是眼科處方藥市場的領導者。我們具備符合醫療現場需求的多種疾病領域的治療藥,擁有國內最多的MR(醫藥信息擔當者)和有絕對優勢的信息提供和收集能力,為日本全國的眼科醫生提供細致的服務。在海外,美國、歐洲、亞洲等各國都擁有基地,進行眼科藥的開發、生產和銷售.
[抗風濕藥]
參天制藥的另一個支柱是抗風濕藥品領域。在關節風濕治療領域里我們向醫療現場提供被稱為DMARDs(Disease Modifying Anti-rheumatic Drugs:疾病修飾性抗風濕藥)的3個品種的處方藥。同時在加強研究開發繼這3個品種之后的新抗風濕藥品。
■非處方藥
1897年「大學眼藥」開始銷售以來,參天制藥100多年來著眼于簡易治療和眼病預防進行了非處方滴眼劑的開發、生產、銷售。并從提高便利性的角度出發,將很多具有獨創性的構思應用到了產品當中,1962年在日本率先采用塑料材質的滴眼劑容器是一個具有代表性的例子。主要的產品有「SenteFXneo」、「Santedo」系列、「Sante40」系列等.
■醫療器械
作為眼科領域的專家,對醫療機構提供醫藥品以外的產品、服務,這一醫療器械事業也是參天制藥的一個強項。主要銷售白內障手術所使用的超音波白內障手術裝置,眼內鏡片,手術用的一些物品等。2001年11月,收購了以眼內鏡片的研究、開發、生產、銷售為主的美國的Advanced?Vision?Science?Inc.,進一步加強了眼內鏡片的產品開發力量.
[Prescription Ophthalmics]
Santen leads the Japanese market for prescription ophthalmics with a share of nearly 40 percent. We offer treatments for a wide range of ophthalmic disorders and covers ophthalmologists nationwide with the largest number of medical representatives in Japan. We also have overseas bases in the United States, Europe and Asian countries for the development, production and sale of ophthalmic pharmaceuticals.
[Anti-rheumatic Pharmaceuticals]
Santen's second largest business area is anti-rheumatic pharmaceuticals, and we provide three disease modifying anti-rheumatic drugs (DMARDs) to healthcare institutions throughout Japan for the treatment of rheumatoid arthritis. Furthermore, we are strengthening our research and development efforts to develop new anti-rheumatic drugs to succeed these two products.
Over-the-Counter (OTC) Pharmaceuticals
Since the launch of Daigaku Eye Drops in 1899, Santen has been committed to the development, production and marketing of superior OTC ophthalmic products, with a focus on basic treatment and eye disease prevention. A consistent emphasis on creativity and innovation, such as introducing Japan's first plastic eye drop container in 1962, highlights Santen's determination to put numerous innovative ideas into practice. Major OTC products include Sante FX Neo , the Sante de u series and the Sante 40 series, which have been well-recognized among Japanese consumers for many years.
Medical Devices
Santen participates in the ophthalmic devices market as an expert in the field of ophthalmology, and the ability to provide products and services to medical institutions in addition to pharmaceuticals illustrates our strength. Our main products include phacoemulsification machines for cataract surgery, intraocular lenses and surgical instruments. In November 2001, Santen strengthened its ability to develop intraocular lenses by acquiring the U.S. company Advanced Vision Science, Inc., which is involved in the research, development, production and marketing of intraocular lenses.